Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum THC Biomed Intl Ltd THCBF


Primary Symbol: C.THC

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed... see more

CSE:THC - Post Discussion

THC Biomed Intl Ltd > John Miller
View:
Post by wildabeastboy on Oct 16, 2022 8:38pm

John Miller

Your company shares are now priced at .03. You are a coward and a fraud. You have always been a coward. Fraud is the new THC BIOMED company "motto" No announcements come from a coward. No product rollout Comes from a coward. No profit for shareholders comes from a coward. Silence comes from a coward. Your CFO is also a coward. THC BIOMED is a company managed by incompetent cowards. Enjoy your trip to Kelowna Andre.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities